FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020503528> ?p ?o ?g. }

• W2020503528 endingPage "192" @default.
• W2020503528 startingPage "188" @default.
• W2020503528 abstract "Introduction: In 2012, the Veterans Affairs (VA) Pharmacy Benefits Management Services created recommendations for antipsychotic selection in schizophrenia and schizoaffective disorders. The recommendations stated that patients must fail two first line agents (haloperidol, loxapine, quetiapine, risperidone or perphenazine) and clozapine (if appropriate) before being allowed to trial second line agents olanzapine, ziprasidone or aripiprazole. The aim of this project was to determine the amount of cost savings that could have been provided had the above recommendations been implemented last year. Use of second generation antipsychotics has been associated with weight gain, diabetes, and worsening lipid profiles. The American Diabetes Association (ADA) has created guidelines regarding cardiometabolic monitoring of second generation antipsychotic agents. A secondary aim of this project was to determine the rate of provider adherence to the ADA recommendations. Methods: A retrospective chart review was performed for patients &gt;18 years of age who were initiated on aripiprazole, ziprasidone, or olanzapine for all indications between July 1, 2011 and July 1, 2012. The costs of the mean doses of these agents were compared to an equivalent mean dose of the first line agent risperidone (4mg) using VA drug acquisition costs. Cardiometabolic monitoring data were collected to include weight, blood pressure, fasting glucose and fasting lipid profiles at baseline and at 12 weeks. Results: Of the 542 patients started on second line agents, only 68 met criteria for their use. A potential cost savings of over $850,000 may have been realized had these criteria been enacted within the one year time period studied. None of the 542 patients had both baseline and follow-up values for weight, blood pressure, fasting glucose and fasting lipid profiles. While roughly 60% of patients had blood pressure and weight values at baseline and 27% had glucose and cholesterol values, less than 14% received follow-up testing with approximately 2% receiving neither baseline nor follow-up testing. Discussion: Significant cost savings can be realized via the use of selection criteria without sacrificing efficacy as most studies do not demonstrate the superiority of one agent and the rates of adverse events between first and second generation agents are more similar than previously thought. This study also highlighted the lack of adequate cardiometabolic monitoring which could lead to cardiovascular disease." @default.
• W2020503528 created "2016-06-24" @default.
• W2020503528 creator A5022438325 @default.
• W2020503528 creator A5052956410 @default.
• W2020503528 creator A5054591762 @default.
• W2020503528 date "2013-10-01" @default.
• W2020503528 modified "2023-09-26" @default.
• W2020503528 title "Implementation of antipsychotic selection recommendations at a veterans affairs facility" @default.
• W2020503528 cites W2012355684 @default.
• W2020503528 cites W2022211242 @default.
• W2020503528 cites W2101228291 @default.
• W2020503528 cites W2120028475 @default.
• W2020503528 cites W2133198672 @default.
• W2020503528 cites W2147717090 @default.
• W2020503528 cites W2151872428 @default.
• W2020503528 cites W2152770536 @default.
• W2020503528 cites W2159155203 @default.
• W2020503528 cites W2168875379 @default.
• W2020503528 cites W2171958702 @default.
• W2020503528 cites W2326662527 @default.
• W2020503528 cites W2591325903 @default.
• W2020503528 cites W1967291383 @default.
• W2020503528 doi "https://doi.org/10.9740/mhc.n172352" @default.
• W2020503528 hasPublicationYear "2013" @default.
• W2020503528 type Work @default.
• W2020503528 sameAs 2020503528 @default.
• W2020503528 citedByCount "1" @default.
• W2020503528 countsByYear W20205035282015 @default.
• W2020503528 crossrefType "journal-article" @default.
• W2020503528 hasAuthorship W2020503528A5022438325 @default.
• W2020503528 hasAuthorship W2020503528A5052956410 @default.
• W2020503528 hasAuthorship W2020503528A5054591762 @default.
• W2020503528 hasBestOaLocation W20205035281 @default.
• W2020503528 hasConcept C118552586 @default.
• W2020503528 hasConcept C126322002 @default.
• W2020503528 hasConcept C194828623 @default.
• W2020503528 hasConcept C2775969662 @default.
• W2020503528 hasConcept C2776412080 @default.
• W2020503528 hasConcept C2776619155 @default.
• W2020503528 hasConcept C2776921671 @default.
• W2020503528 hasConcept C2777270317 @default.
• W2020503528 hasConcept C2780057945 @default.
• W2020503528 hasConcept C2780211496 @default.
• W2020503528 hasConcept C2780494398 @default.
• W2020503528 hasConcept C2780634440 @default.
• W2020503528 hasConcept C2780864610 @default.
• W2020503528 hasConcept C71924100 @default.
• W2020503528 hasConceptScore W2020503528C118552586 @default.
• W2020503528 hasConceptScore W2020503528C126322002 @default.
• W2020503528 hasConceptScore W2020503528C194828623 @default.
• W2020503528 hasConceptScore W2020503528C2775969662 @default.
• W2020503528 hasConceptScore W2020503528C2776412080 @default.
• W2020503528 hasConceptScore W2020503528C2776619155 @default.
• W2020503528 hasConceptScore W2020503528C2776921671 @default.
• W2020503528 hasConceptScore W2020503528C2777270317 @default.
• W2020503528 hasConceptScore W2020503528C2780057945 @default.
• W2020503528 hasConceptScore W2020503528C2780211496 @default.
• W2020503528 hasConceptScore W2020503528C2780494398 @default.
• W2020503528 hasConceptScore W2020503528C2780634440 @default.
• W2020503528 hasConceptScore W2020503528C2780864610 @default.
• W2020503528 hasConceptScore W2020503528C71924100 @default.
• W2020503528 hasIssue "4" @default.
• W2020503528 hasLocation W20205035281 @default.
• W2020503528 hasOpenAccess W2020503528 @default.
• W2020503528 hasPrimaryLocation W20205035281 @default.
• W2020503528 hasRelatedWork W1509131650 @default.
• W2020503528 hasRelatedWork W2020503528 @default.
• W2020503528 hasRelatedWork W2026895621 @default.
• W2020503528 hasRelatedWork W2036715112 @default.
• W2020503528 hasRelatedWork W2044803716 @default.
• W2020503528 hasRelatedWork W2076034178 @default.
• W2020503528 hasRelatedWork W2076855008 @default.
• W2020503528 hasRelatedWork W2088052920 @default.
• W2020503528 hasRelatedWork W2357461257 @default.
• W2020503528 hasRelatedWork W3038440250 @default.
• W2020503528 hasVolume "3" @default.
• W2020503528 isParatext "false" @default.
• W2020503528 isRetracted "false" @default.
• W2020503528 magId "2020503528" @default.
• W2020503528 workType "article" @default.